IntelliPharmaCeutics International (IntelliPharmaCeutics International) EPS (Basic) : $-0.09 (TTM As of Aug. 2023)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International EPS (Basic)?

IntelliPharmaCeutics International's basic earnings per share (Basic EPS) for the three months ended in Aug. 2023 was $-0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Aug. 2023 was $-0.09.

IntelliPharmaCeutics International's EPS (Diluted) for the three months ended in Aug. 2023 was $-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was $-0.09.

IntelliPharmaCeutics International's EPS without NRI for the three months ended in Aug. 2023 was $-0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Aug. 2023 was -0.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

IntelliPharmaCeutics International EPS (Basic) Historical Data

The historical data trend for IntelliPharmaCeutics International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International EPS (Basic) Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

EPS (Basic)

Get a 7-Day Free Trial

-2.89

-0.37

-0.14

-0.17

-0.09

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.02	-0.01	-	-0.06

IntelliPharmaCeutics International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

IntelliPharmaCeutics International's Basic EPS for the fiscal year that ended in Nov. 2022 is calculated as

Basic EPS (A: Nov. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.892	-	0)	/	33.093
	=	-0.09

IntelliPharmaCeutics International's Basic EPS for the quarter that ended in Aug. 2023 is calculated as

Basic EPS (Q: Aug. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.889	-	0)	/	33.093
	=	-0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09

IntelliPharmaCeutics International (OTCPK:IPCIF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

IntelliPharmaCeutics International EPS (Basic) Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.